U.S. Cell And Gene Therapy Manufacturing Market Size & Outlook

Name: U.S. Cell And Gene Therapy Manufacturing Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The cell and gene therapy manufacturing market in the United States is expected to reach a projected revenue of US$ 21,132.4 million by 2030. A compound annual growth rate of 27.1% is expected of the United States cell and gene therapy manufacturing market from 2023 to 2030.

U.S. cell and gene therapy manufacturing therapy type outlook (Revenue, USD million, 2018-2030)
- Gene Therapy
- Cell Therapy
  - Stem Cell Therapy
  - Non Stem Cell Therapy
U.S. cell and gene therapy manufacturing scale outlook (Revenue, USD million, 2018-2030)
- Pre-commercial/ R&D Scale
- Commercial Scale
U.S. cell and gene therapy manufacturing mode outlook (Revenue, USD million, 2018-2030)
- Contract manufacturing
- In house manufacturing
U.S. cell and gene therapy manufacturing workflow outlook (Revenue, USD million, 2018-2030)
- Cell Processing
- Cell Banking
- Process Development
- Fill & Finish Operations
- Analytical & Quality Testing
- Raw Material Testing
- Vector Production
- Others
U.S. cell and gene therapy manufacturing indication outlook (Revenue, USD million, 2018-2030)
- Acute Lymphoblastic Leukemia (ALL)
- Inherited Retinal Disease
- Malignancies
- Musculoskeletal therapies
- Autoimmune disorders
- Dermatology
- Large B-Cell Lymphoma
- Spinal Muscular Atrophy (SMA)
- Others

U.S. Cell And Gene Therapy Manufacturing Market Size & Outlook

Sign up - it's easy, and free!